Nordic Nanovector ASA: Mandatory notification of trade - primary insider
On 5 July 2017, Dr. Lisa Rojkjaer, MD, the CMO of Nordic Nanovector ASA, purchased 2,000 shares in the company at an average share price of NOK 68.50 per share. Following this transaction, Lisa Rojkjaer owns 4,186 shares in the Company and holds 375,000 options. This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act. About Nordic NanovectorNordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The company aspires to